Purine and pyrimidine analogs differentially regulate cell wall precursor biosynthesis to control β-lactam susceptibility in methicillin-resistant Staphylococcus aureus.

Pyrimidine analogs enhance β-lactam susceptibility in MRSA by impairing cell wall precursor biosynthesis, while purine analog 6-thioguanine often antagonizes this effect.

• Why it matters: Understanding how anticancer drugs targeting nucleotide metabolism influence MRSA antibiotic susceptibility is crucial for optimizing treatment strategies and avoiding drug interactions that may compromise efficacy.
• What they did: The study evaluated several nucleotide metabolism-targeting agents, including pyrimidine and purine analogs, using transcriptomic analysis, fluorescence microscopy, and antibiofilm assays to assess their effects on MRSA.
• The result: Pyrimidine analogs suppressed cell wall synthesis pathways and potentiated β-lactam activity, whereas 6-thioguanine induced amino acid biosynthesis and often antagonized antibiotic effects, highlighting potential for drug repurposing and cautioning against certain combinations.